A survey of management practices for isolated systolic hypertension

Journal of the American Geriatrics Society

Volumn 45, Issue 10, 1997, Pages 1219-1222

  McAlister, Finlay A ^a,b,c   Teo, Koon K ^a   Laupacis, Andreas ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CANADA; CLINICAL PRACTICE; DRUG CHOICE; HUMAN; PRACTICE GUIDELINE; SYSTOLIC HYPERTENSION;

EID: 0030954726     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1997.tb03773.x     Document Type: Article

References (37)

1. Staessen J, Amery A, Fagard R. Isolated systolic hypertension in the elderly. J Hypertens 1990;8:393-405.
2. Borhani NO, Applegate WB, Cutler JA et al. Systolic Hypertension in the Elderly Program (SHEP): Baseline characteristics of the randomized sample, I: Rationale and design. Hypertension 1991;17(Suppl II):2-15.
3. Curb JD, Borhani NO, Entwisle G et al. Isolated systolic hypertension in 14 communities. Am J Epidemiol 1985;121:362-370.
4. Rutan GH, Kuller LH, Neaton JD et al. Mortality associated with diastolic blood pressure and isolated systolic hypertension among men screened for Multiple Risk Factor Intervention Trial. Circulation 1988;77:504-514.
5. Kannel WB, Dawber TR, McGee DL. Perspectives on systolic hypertension. The Framingham Study. Circulation 1980;61:1179-1182.
6. Hypertension Detection and Follow-up Program Cooperative Group. Five year findings of the Hypertension Detection and Follow-up Program. JAMA 1979;242:2562-2571.
7. O'Malley K, McCormack P, O'Brien ET. Isolated systolic hypertension: data from the European Working Party on High Blood Pressure in the Elderly. J Hypertens 1988;6:S105-108.
8. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results for the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
9. Medical Research Council Working Party. Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
10. Reeves RA, Fodor G, Gryfe CI et al. Report of the Canadian Hypertension Society Consensus Conference: 4. Hypertension in the elderly. Can Med Assoc J 1993;149:815-820.
11. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-183.
12. Fotherby MD, Harper GD, Potter JF. General practitioners' management of hypertension in elderly patients. Br Med J 1992;305:750-752.
13. Ribacke M. Treatment preferences, return visit planning and factors affecting hypertension practice amongst general practitioners and internal medicine specialists (The General Practitioner Hypertension Practice Study). J Intern Med 1995;237:473-478.
14. Weiland SK, Keil U, Speisberg A et al. Diagnosis and management of hypertension by physicians in the Federal Republic of Germany. J Hypertens 1991;9:131-134.
15. Steven ID, Wilson DH, Wakefield MA et al. South Australian hypertension survey. General practitioner experiences with drug treatment. Med J Aust 1992;156:641-644.
16. Psaty BM, Savage PJ, Tell GS et al. Temporal patterns of antihypertensive medication use among elderly patients. The Cardiovascular Health Study. JAMA 1993;270:1837-1841.
17. Glynn RJ, Brock DB, Harris T et al. Use of antihypertensive drugs and trends in blood pressure in the elderly. Arch Intern Med 1995;155:1855-1860.
18. Manolio TA, Cutler JA, Furberg CD et al. Trends in pharmacologic management of hypertension in the United States. Arch Intern Med 1995;155:829-837.
19. Steven ID, Wilson DH, Wakefield MA et al. South Australian hypertension survey. General practitioner knowledge and reported management practices: A cause for concern? Med J Aust 1992;156:423-428.
20. Troein M, Arneson T, Rastam L et al. Reported treatment of hypertension by family physicians in Sweden and Minnesota: A physician survey of practice habits. J Intern Med 1995;238:215-221.
21. Lomas J, Anderson GM, Domnick-Pierre K et al. Do practice guidelines guide practice? The effect of a consensus statement on the practice of physicians. N Engl J Med 1989;321:1306-1311.
22. Hartley RM, Charlton JR, Jarman B, Harris CM. Case history questionnaires in the study of doctor's use of resources: Are they measuring what we want? Med Care 1985;23:1163-1170.
23. Lomas J. Words without action? The production, dissemination, and impact of consensus recommendations. Annu Rev Public Health 1991;12:41-65.
24. Holmes M, Rovner D, Rothert M et al. Methods of analyzing physician practice patterns in hypertension. Med Care 1989;27:59-68.
25. White R, Quimby B, Skipper B, Webster G. Cost of residents' decisions on actual patients and in simulated encounters. J Med Educ 1984;59:833-835.
26. Dunn E, Hilditch J, Chipman M et al. Diagnosis and management of hypertension: The stated practices of family physicians. Can Med Assoc J 1984;130:985-988.
27. Diagnosis and management of hypertension. A nationwide survey of physicians' knowledge, attitudes, and reported behavior. Washington, DC: US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung, and Blood Institute, Publication No. 89-2968, September 1989.
28. Edelson JT, Weinstein MC, Tosteson ANA et al. Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension. JAMA 1990;263:407-413.
29. Dalhof B, Lindholm LH, Hansson L et al. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.
30. Chalmers TC. The impact of controlled trials on practice of medicine. Mt Sinai J Med 1974;41:753-759.
31. Boissel JP. Impact of randomized clinical trials on medical practices. Controlled Clin Trials 1989;10:120-134S.
32. Furberg CD. The impact of clinical trials on clinical practice. Arzneimittel-Forschung 1989;39:986-988.
33. Lamas GA, Pfeffer MA, Hamm P et al for the SAVE Investigators. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? N Engl J Med 1992;327:241-247.
34. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: A systematic review of rigorous evaluations. Lancet 1993;342:1317-1322.
35. Kosecoff J, Kanouse DE, Rogers WH et al. Effects of the National Institutes of Health consensus development program on physician practice. JAMA 1987;258:2708-2713.
36. Col NF, McLaughlin TJ, Soumerai SB et al. The impact of clinical trials on the use of medications for acute myocardial infarction: Results of a community-based study. Arch Intern Med 1996;156:54-60.
37. Brand DA, Newcomer LN, Freiburger A, Tian H. Cardiologists' practices compared with practice guidelines: Use of beta-blockade after acute myocardial infarction. J Am Coll Cardiol 1995;26:1432-1436.